Sterility Indicators Market Analysis

Sterility Indicators Market Analysis

The report classifies global sterility indicators market into chemical and biological indicators. The biological category registered over 58% business share in 2021. Biological indicators indicate whether the criteria for any sterilization process to eliminate a specific number of germs is satisfied or not. When compared to chemical indicators, BIs produce more accurate readings and are regarded as the industry's gold standard for determining sterilization accuracy. Furthermore, BIs in the form of spore ampoules are used more commonly because they contain extremely resistant spores inside a container and may be used in a range of techniques such as liquid sterilization, steam sterilization, and radiation sterilization, which is expected to spur the market for biological indicators.
 

Based on technique, the industry is categorized into filtration sterilization, low-temperature sterilization, radiation sterilization, liquid sterilization, and heat sterilization. The liquid sterilization segment is projected to expand at over 8.5% CAGR during the analysis period. When compared to other disinfection processes, liquid sterilization is the most preferred technique. The technique can kill both resistant bacteria (spores) and fungus. It ensures a higher level of germ elimination for heat-sensitive medical devices. It is also ideal for sanitizing the outer surface of things. With growing concern about sanitization in the aftermath of the pandemic, the liquid sterilization technology is in high demand, which will boost the overall market size.
 

In terms of end-use, worldwide sterility indicators market is divided into research centers, medical device companies, pharmaceutical companies, hospitals, and others. The pharmaceutical companies segment held more than 24% revenue share in 2021, owing to increasing usage of sterility indicators to conduct sterility testing as part of quality assurance during product manufacture. Chemical and biological indicators allow testing for a variety of applications in pharmaceutical companies. They employ BIs, for example, in process challenge devices (PCD) for conventional autoclave sterilization testing and the passing result showcase effective sterilization cycle. The level of assurance offered by sterility devices to Sterile Processing Department is fostering the product demand in pharmaceutical companies.
 

Europe sterility indicators market is expected to grow at over 8.5% CAGR during the research period. This is owing to growing awareness regarding sterilization across the region, surge in number of healthcare facilities, and increasing medical spending power of populace. The existence of various market participants who are focused on developing new effective solutions to improve sterilization control in hospitals and pharmaceutical companies will augment the regional market outlook.